Actively Recruiting
Online ACT and Education Programs for Disorders of Gut-Brain Interaction Evaluating Effectiveness and Cost-Effectiveness
Led by Örebro University, Sweden · Updated on 2026-10-23
200
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and cost-efficiency of an online intervention called iACTforDGBI compared to an active control group named DGBI School. This study focuses on adults aged 18 to 75 years who have Disorders of Gut-Brain Interaction DGBI and psychological distress. The trial aims to assess treatment impact on depressive, gastrointestinal, and anxiety symptoms, among other health-related outcomes. Participants are randomly assigned to one of two groups the experimental group receives an online intervention based on Acceptance and Commitment Therapy ACT, mindfulness, and compassion across 8 sessions, while the control group receives education about DGBI, diet, and psychological factors through the DGBI School program. Both interventions are delivered online, and the study uses a double-blind design. During the study, participants complete assessments at baseline, week 4, week 8, and follow-ups at 3 and 6 months. These assessments measure symptoms of depression, gastrointestinal issues, and anxiety using standardized questionnaires. Additional evaluations include quality of life, healthcare use, psychological flexibility, self-compassion, treatment credibility, system usability, and potential negative effects. The study is sponsored by rebro University in Sweden and is expected to conclude by September 2027.
CONDITIONS
Brief Title
Efficacy, and Cost-effectiveness of an Online ACT Intervention for Disorders of Gut-Brain Interaction (iACTforDGBI)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here